Unlike everyone else, the drug and device licensing world is NOT facing an economic crisis. Billions of dollars are now available to drug and device companies developing novel treatments, and even more money is ready to be made by companies that acquire the rights to sell them. But companies must be smart in how they devise and structure their agreements.

In a new BioWorld Today and Medical Device Daily audio conference, consultant Alan Schechter will guide you through the maze of licensing options, indentify the common pitfalls in developing licensing agreements, and provide strategies for making sound licensing decisions in the regulated environment.

"Drug and Device Licensing: Formulate the Right Agreement" is just $349 per listening site. Scheduled for January 21st, from 1-2:30 p.m., it includes presentation handouts and a Q&A session with the speaker. A conference CD (MP3 format) is also available. Please call 800-688-2421 or 404-262-5474 and mention conference code T09531.